Cart (0)
Your shopping cart is empty!
New
Lioton 1000 Gel for external use 100g
Lioton 1000 Gel for external use 100g
Product Code: lioton-100

Lioton 1000 Gel for external use 100g

Compare this Product
$35.50
8


Composition

Per 100 g of gel:
Active substance: sodium heparin - 100 000 IU
Excipients: carbomer, methylparahydroxybenzoate, propylparahydroxybenzoate, ethanol 96%, neroli oil, lavender oil, trolamine (triethanolamine), purified water.
Pharmacological action

Pharmacotherapeutic group: direct-acting anticoagulant agent for topical use

ATCH CODE: C05VA03

Pharmacological properties

Pharmacodynamics
Sodium heparin is a direct-acting anticoagulant. It prevents thrombosis, inhibits hyaluronidase activity, activates fibrinolytic properties of blood.

When applied topically, it has a local antithrombotic, anti-edematous and anti-inflammatory effect, improves blood microcirculation and activates tissue metabolism, which accelerates the resorption of hematomas and blood clots, reduces swelling of tissues.

Pharmacokinetics
Insignificant amount of heparin is absorbed from the skin surface into the systemic bloodstream. The maximum concentration of the drug in the blood is observed 8 hours after application. Excretion of heparin mainly occurs through the kidneys, half-life is 12 hours. It does not penetrate the placental barrier.
Indications

    Superficial vein diseases: varicose veins, chronic venous insufficiency and related complications (superficial thrombophlebitis, superficial periphlebitis);
    blunt traumas and soft tissue contusions;
    subcutaneous hematomas, including hematomas after vein surgeries, phlebectomy;
    localized infiltrates and edema of soft tissues.

Use in pregnancy and lactation
Lyoton® 1000 may be used in pregnancy and during breastfeeding if the expected benefit to the mother exceeds the potential risk to the fetus and child. Heparin does not penetrate through the placental barrier and into breast milk. Due to insignificant absorption of heparin during external application, the drug has no systemic effect on the body. However, before using Lyoton® 1000 in pregnancy and during breastfeeding it is necessary to consult a doctor.
Contraindications

    hypersensitivity to heparin or other components of the drug;
    violation of skin integrity at the site of application of the drug (ulcerative-necrotic skin changes); traumatic violations of skin integrity (open wounds);
    increased tendency to bleeding, thrombocytopenia;
    age under 18 years (safety and efficacy of the drug has not been studied).

Side effects
In very rare cases (< 1/10000), hypersensitivity reactions to heparin may occur during external application. In some cases (frequency unknown: it is impossible to estimate according to the available data) may be observed allergic reactions to the components of the drug, manifested by redness of the skin and / or itching, which usually pass after discontinuation of the drug. If you have side effects specified in the instructions, or they worsen, or you notice any other side effects not specified in the instructions, inform your doctor.
Interaction

With prolonged use of heparin on large areas of the skin and concomitant use of indirect anticoagulants (warfarin, acenocoumarol, etc.), prothrombin time and clotting time should be monitored.

It is not recommended to mix with other agents for external use. Concomitant use with topical preparations containing tetracyclines, antihistamines or non-steroidal anti-inflammatory drugs is not recommended. If you use the above or other medicines (including over-the-counter), consult your doctor before using Lyoton® 1000.


How to take, course of treatment and dosage

Externally.
A small amount of gel (3-10 cm) 1-3 times a day apply a thin layer to the affected area and gently rub into the skin.

In diseases of superficial veins:

at the initial symptoms of venous insufficiency ("heaviness", pain in the legs, venous edema) to apply for 1-3 weeks depending on the severity of symptoms;

in chronic venous insufficiency apply for 4-6 weeks depending on the severity of symptoms, apply for no more than 6 weeks;

In blunt injuries and bruises of soft tissues: the course of treatment for 5-7 days or until the disappearance of symptoms, apply for no more than 10 days;

With subcutaneous hematomas, including hematomas after vein surgeries, phlebectomy: treatment course 7-21 days or until symptoms disappear, apply for no more than 4 weeks.

In localized infiltrates and edema of soft tissues: treatment course 4-6 weeks or until the disappearance of symptoms, apply for no more than 6 weeks.

The necessity of further treatment is determined by a doctor.

If during the treatment period there is no improvement or symptoms worsen, or new symptoms appear, it is necessary to consult a doctor. Use the drug only according to the indications, the method of administration and in the doses indicated in the instructions.
Overdose
To date, information about cases of overdose has not been registered. In case of overdose, the effect of heparin can be neutralized by administration of protamine sulfate solution.
Description
Colorless or with a slightly yellowish tint, almost transparent gel of viscous consistency with a characteristic odor.
Special instructions

It is not recommended to apply to mucous membranes, open wounds and use in the presence of purulent lesions in the intended place of application of the gel.

Lyoton® 1000 is not recommended for deep vein thrombosis. Methylparahydroxybenzoate and propylparahydroxybenzoate included in Lyoton® 1000 preparation may cause allergic reactions (including delayed type).

Effect on the ability to drive vehicles and mechanisms
Administration of the drug does not affect the ability to drive vehicles and engage in other potentially dangerous activities requiring increased concentration and quickness of psychomotor reactions.
Form of release
Gel for external application, 1000 IU/g. 30 g, 50 g or 100 g of the preparation in aluminum tubes, coated from the inside with epoxy resin, with a screw cap (polyethylene/polypropylene). 1 tube with instructions for use of the drug in a cardboard pack.
Storage conditions
At a temperature not exceeding 25 ° C. Keep out of reach of children!